[시장보고서]점안 안약 전달 기술 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

점안 안약 전달 기술 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

Ocular Drug Delivery Technology Market (Technology: Topical, Ocular Insert, Iontophoresis, Intraocular Implant, In Situ Gel & Punctal Plug, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

상품코드 : 1487587

리서치사 : Transparency Market Research

발행일 : 2024년 04월

페이지 정보 : 영문 214 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,598,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 13,049,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 17,500,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

점안 안약 전달 기술 시장- 조사 범위

TMR의 조사 보고서 "세계 점안 안약 전달 기술 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사하여 2024년을 기준 연도로, 2034년을 예측 연도로 삼았습니다. 으로 2018년부터 2034년까지 세계 점안 안약 전달 기술 시장의 수익을 제공합니다. 또한 2024년부터 2034년까지 세계 점안 안약 전달 기술 시장의 연평균 복합 성장률(CAGR%)을 제공합니다.

이 보고서는 1차 조사에서 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하고, 2차 조사에서 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참조하여 경구용 약물 전달 기술 시장을 이해하고자 했습니다. 기술 시장을 이해했습니다.

시장 현황
2023년 시장 규모	163억 달러
2034년 시장 가치	302억 달러
CAGR	5.7%

이 보고서는 세계 경구용 약물 전달 기술 시장 경쟁 구도를 심층적으로 분석합니다. 세계 점안 안약 전달 기술 시장에서 활동하는 주요 업체를 식별하고, 각 업체는 다양한 속성으로 프로파일링됩니다. 기업 개요, 재무 상태, 최근 동향 및 SWOT는 이 보고서에서 다루는 세계 경안 약물 전달 기술 시장 기업의 속성입니다.

시장 경쟁 매트릭스(기업 Tier별, 기업 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
- Ocular Therapeutix, Inc.
- Alimera Sciences Inc.
- Allergan(an AbbVie company)
- Bausch Health Companies Inc.
- EyeGate Pharmaceuticals, Inc.
- Envisia Therapeutics Inc.
- Clearside Biomedical, Inc.
- Graybug Vision, Inc.
- Santen Pharmaceutical Co., Ltd.
- Taiwan Liposome Company, Ltd.

LSH

영문 목차

영문목차

Ocular Drug Delivery Technology Market - Scope of Report

TMR's report on the global ocular drug delivery technology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global ocular drug delivery technology market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ocular drug delivery technology market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ocular drug delivery technology market.

Market Snapshot
Market Value in 2023	US$ 16.3 Bn
Market Value in 2034	US$ 30.2 Bn
CAGR	5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global ocular drug delivery technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global ocular drug delivery technology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global ocular drug delivery technology market.

The report delves into the competitive landscape of the global ocular drug delivery technology market. Key players operating in the global ocular drug delivery technology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global ocular drug delivery technology market profiled in this report.

Key Questions Answered in Global ocular drug delivery technology Market Report:

What is the sales/revenue generated by ocular drug delivery technology across all regions during the forecast period?
What are the opportunities in the global ocular drug delivery technology market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Ocular Drug Delivery Technology Market - Research Objectives and Research Approach

The comprehensive report on the global ocular drug delivery technology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global ocular drug delivery technology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global ocular drug delivery technology market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ocular Drug Delivery Technology Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Ocular Drug Delivery Technology Market Analysis and Forecast, 2020-2034

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Technology

6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2020-2034
- 6.3.1. Topical
- 6.3.2. Ocular Insert
  - 6.3.2.1. Erodible
  - 6.3.2.2. Non-erodible
- 6.3.3. Iontophoresis
- 6.3.4. Intraocular Implant
  - 6.3.4.1. Biodegradable
  - 6.3.4.2. Non-biodegradable
- 6.3.5. In Situ Gel & Punctal Plug
- 6.3.6. Others
6.4. Market Attractiveness, by Technology

7. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Formulation Type

7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Formulation Type, 2020-2034
- 7.3.1. Solution
- 7.3.2. Suspension
- 7.3.3. Emulsion
- 7.3.4. Liposome & Nanoparticle
- 7.3.5. Ointment
7.4. Market Attractiveness, by Formulation Type

8. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Disease Type

8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Disease Type, 2020-2034
- 8.3.1. Glaucoma
- 8.3.2. Macular Degeneration
- 8.3.3. Diabetic Retinopathy
- 8.3.4. Cataract
- 8.3.5. Diabetic Macular Edema
- 8.3.6. Dry Eye Syndrome
- 8.3.7. Others
8.4. Market Attractiveness, by Disease Type

9. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by End-user

9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
- 9.3.1. Hospitals
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. Ophthalmic Clinics
- 9.3.4. Homecare Settings
9.4. Market Attractiveness, by End-user

10. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Region

10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region

11. North America Ocular Drug Delivery Technology Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Technology, 2020-2034
- 11.2.1. Topical
- 11.2.2. Ocular Insert
  - 11.2.2.1. Erodible
  - 11.2.2.2. Non-erodible
- 11.2.3. Iontophoresis
- 11.2.4. Intraocular Implant
  - 11.2.4.1. Biodegradable
  - 11.2.4.2. Non-biodegradable
- 11.2.5. In Situ Gel & Punctal Plug
- 11.2.6. Others
11.3. Market Attractiveness, by Technology
11.4. Market Value Forecast, by Formulation Type, 2020-2034
- 11.4.1. Solution
- 11.4.2. Suspension
- 11.4.3. Emulsion
- 11.4.4. Liposome & Nanoparticle
- 11.4.5. Ointment
11.5. Market Attractiveness, by Formulation Type
11.6. Market Value Forecast, by Disease Type, 2020-2034
- 11.6.1. Glaucoma
- 11.6.2. Macular Degeneration
- 11.6.3. Diabetic Retinopathy
- 11.6.4. Cataract
- 11.6.5. Diabetic Macular Edema
- 11.6.6. Dry Eye Syndrome
- 11.6.7. Others
11.7. Market Attractiveness, by Disease Type
11.8. Market Value Forecast, by End-user, 2020-2034
- 11.8.1. Hospitals
- 11.8.2. Ambulatory Surgical Centers
- 11.8.3. Ophthalmic Clinics
- 11.8.4. Homecare Settings
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country, 2020-2034
- 11.10.1. U.S.
- 11.10.2. Canada
11.11. Market Attractiveness Analysis
- 11.11.1. By Technology
- 11.11.2. By Formulation Type
- 11.11.3. By Disease Type
- 11.11.4. By End-user
- 11.11.5. By Country

12. Europe Ocular Drug Delivery Technology Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Technology, 2020-2034
- 12.2.1. Topical
- 12.2.2. Ocular Insert
  - 12.2.2.1. Erodible
  - 12.2.2.2. Non-erodible
- 12.2.3. Iontophoresis
- 12.2.4. Intraocular Implant
  - 12.2.4.1. Biodegradable
  - 12.2.4.2. Non-biodegradable
- 12.2.5. In Situ Gel & Punctal Plug
- 12.2.6. Others
12.3. Market Attractiveness, by Technology
12.4. Market Value Forecast, by Formulation Type, 2020-2034
- 12.4.1. Solution
- 12.4.2. Suspension
- 12.4.3. Emulsion
- 12.4.4. Liposome & Nanoparticle
- 12.4.5. Ointment
12.5. Market Attractiveness, by Formulation Type
12.6. Market Value Forecast, by Disease Type, 2020-2034
- 12.6.1. Glaucoma
- 12.6.2. Macular Degeneration
- 12.6.3. Diabetic Retinopathy
- 12.6.4. Cataract
- 12.6.5. Diabetic Macular Edema
- 12.6.6. Dry Eye Syndrome
- 12.6.7. Others
12.7. Market Attractiveness, by Disease Type
12.8. Market Value Forecast, by End-user, 2020-2034
- 12.8.1. Hospitals
- 12.8.2. Ambulatory Surgical Centers
- 12.8.3. Ophthalmic Clinics
- 12.8.4. Homecare Settings
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
- 12.10.1. Germany
- 12.10.2. U.K.
- 12.10.3. France
- 12.10.4. Italy
- 12.10.5. Spain
- 12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
- 12.11.1. By Technology
- 12.11.2. By Formulation Type
- 12.11.3. By Disease Type
- 12.11.4. By End-user
- 12.11.5. By Country/Sub-region

13. Asia Pacific Ocular Drug Delivery Technology Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Technology, 2020-2034
- 13.2.1. Topical
- 13.2.2. Ocular Insert
  - 13.2.2.1. Erodible
  - 13.2.2.2. Non-erodible
- 13.2.3. Iontophoresis
- 13.2.4. Intraocular Implant
  - 13.2.4.1. Biodegradable
  - 13.2.4.2. Non-biodegradable
- 13.2.5. In Situ Gel & Punctal Plug
- 13.2.6. Others
13.3. Market Attractiveness, by Technology
13.4. Market Value Forecast, by Formulation Type, 2020-2034
- 13.4.1. Solution
- 13.4.2. Suspension
- 13.4.3. Emulsion
- 13.4.4. Liposome & Nanoparticle
- 13.4.5. Ointment
13.5. Market Attractiveness, by Formulation Type
13.6. Market Value Forecast, by Disease Type, 2020-2034
- 13.6.1. Glaucoma
- 13.6.2. Macular Degeneration
- 13.6.3. Diabetic Retinopathy
- 13.6.4. Cataract
- 13.6.5. Diabetic Macular Edema
- 13.6.6. Dry Eye Syndrome
- 13.6.7. Others
13.7. Market Attractiveness, by Disease Type
13.8. Market Value Forecast, by End-user, 2020-2034
- 13.8.1. Hospitals
- 13.8.2. Ambulatory Surgical Centers
- 13.8.3. Ophthalmic Clinics
- 13.8.4. Homecare Settings
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
- 13.10.1. China
- 13.10.2. Japan
- 13.10.3. India
- 13.10.4. Australia & New Zealand
- 13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
- 13.11.1. By Technology
- 13.11.2. By Formulation Type
- 13.11.3. By Disease Type
- 13.11.4. By End-user
- 13.11.5. By Country/Sub-region

14. Latin America Ocular Drug Delivery Technology Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Technology, 2020-2034
- 14.2.1. Topical
- 14.2.2. Ocular Insert
  - 14.2.2.1. Erodible
  - 14.2.2.2. Non-erodible
- 14.2.3. Iontophoresis
- 14.2.4. Intraocular Implant
  - 14.2.4.1. Biodegradable
  - 14.2.4.2. Non-biodegradable
- 14.2.5. In Situ Gel & Punctal Plug
- 14.2.6. Others
14.3. Market Attractiveness, by Technology
14.4. Market Value Forecast, by Formulation Type, 2020-2034
- 14.4.1. Solution
- 14.4.2. Suspension
- 14.4.3. Emulsion
- 14.4.4. Liposome & Nanoparticle
- 14.4.5. Ointment
14.5. Market Attractiveness, by Formulation Type
14.6. Market Value Forecast, by Disease Type, 2020-2034
- 14.6.1. Glaucoma
- 14.6.2. Macular Degeneration
- 14.6.3. Diabetic Retinopathy
- 14.6.4. Cataract
- 14.6.5. Diabetic Macular Edema
- 14.6.6. Dry Eye Syndrome
- 14.6.7. Others
14.7. Market Attractiveness, by Disease Type
14.8. Market Value Forecast, by End-user, 2020-2034
- 14.8.1. Hospitals
- 14.8.2. Ambulatory Surgical Centers
- 14.8.3. Ophthalmic Clinics
- 14.8.4. Homecare Settings
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
- 14.10.1. Brazil
- 14.10.2. Mexico
- 14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
- 14.11.1. By Technology
- 14.11.2. By Formulation Type
- 14.11.3. By Disease Type
- 14.11.4. By End-user
- 14.11.5. By Country/Sub-region

15. Middle East & Africa Ocular Drug Delivery Technology Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Technology, 2020-2034
- 15.2.1. Topical
- 15.2.2. Ocular Insert
  - 15.2.2.1. Erodible
  - 15.2.2.2. Non-erodible
- 15.2.3. Iontophoresis
- 15.2.4. Intraocular Implant
  - 15.2.4.1. Biodegradable
  - 15.2.4.2. Non-biodegradable
- 15.2.5. In Situ Gel & Punctal Plug
- 15.2.6. Others
15.3. Market Attractiveness, by Technology
15.4. Market Value Forecast, by Formulation Type, 2020-2034
- 15.4.1. Solution
- 15.4.2. Suspension
- 15.4.3. Emulsion
- 15.4.4. Liposome & Nanoparticle
- 15.4.5. Ointment
15.5. Market Attractiveness, by Formulation Type
15.6. Market Value Forecast, by Disease Type, 2020-2034
- 15.6.1. Glaucoma
- 15.6.2. Macular Degeneration
- 15.6.3. Diabetic Retinopathy
- 15.6.4. Cataract
- 15.6.5. Diabetic Macular Edema
- 15.6.6. Dry Eye Syndrome
- 15.6.7. Others
15.7. Market Attractiveness, by Disease Type
15.8. Market Value Forecast, by End-user, 2020-2034
- 15.8.1. Hospitals
- 15.8.2. Ambulatory Surgical Centers
- 15.8.3. Ophthalmic Clinics
- 15.8.4. Homecare Settings
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
- 15.10.1. GCC Countries
- 15.10.2. South Africa
- 15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
- 15.11.1. By Technology
- 15.11.2. By Formulation Type
- 15.11.3. By Disease Type
- 15.11.4. By End-user
- 15.11.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
- 16.3.1. Ocular Therapeutix, Inc.
  - 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.1.2. Product Portfolio
  - 16.3.1.3. Financial Overview
  - 16.3.1.4. SWOT Analysis
  - 16.3.1.5. Strategic Overview
- 16.3.2. Alimera Sciences Inc.
  - 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.2.2. Product Portfolio
  - 16.3.2.3. Financial Overview
  - 16.3.2.4. SWOT Analysis
  - 16.3.2.5. Strategic Overview
- 16.3.3. Allergan (an AbbVie company)
  - 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.3.2. Product Portfolio
  - 16.3.3.3. Financial Overview
  - 16.3.3.4. SWOT Analysis
  - 16.3.3.5. Strategic Overview
- 16.3.4. Bausch Health Companies Inc.
  - 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.4.2. Product Portfolio
  - 16.3.4.3. Financial Overview
  - 16.3.4.4. SWOT Analysis
  - 16.3.4.5. Strategic Overview
- 16.3.5. EyeGate Pharmaceuticals, Inc.
  - 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.5.2. Product Portfolio
  - 16.3.5.3. Financial Overview
  - 16.3.5.4. SWOT Analysis
  - 16.3.5.5. Strategic Overview
- 16.3.6. Envisia Therapeutics Inc.
  - 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.6.2. Product Portfolio
  - 16.3.6.3. Financial Overview
  - 16.3.6.4. SWOT Analysis
  - 16.3.6.5. Strategic Overview
- 16.3.7. Clearside Biomedical, Inc.
  - 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.7.2. Product Portfolio
  - 16.3.7.3. Financial Overview
  - 16.3.7.4. SWOT Analysis
  - 16.3.7.5. Strategic Overview
- 16.3.8. Graybug Vision, Inc.
  - 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.8.2. Product Portfolio
  - 16.3.8.3. Financial Overview
  - 16.3.8.4. SWOT Analysis
  - 16.3.8.5. Strategic Overview
- 16.3.9. Santen Pharmaceutical Co., Ltd.
  - 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.9.2. Product Portfolio
  - 16.3.9.3. Financial Overview
  - 16.3.9.4. SWOT Analysis
  - 16.3.9.5. Strategic Overview
- 16.3.10. Taiwan Liposome Company, Ltd.
  - 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.10.2. Product Portfolio
  - 16.3.10.3. Financial Overview
  - 16.3.10.4. SWOT Analysis
  - 16.3.10.5. Strategic Overview

한글목차

점안 안약 전달 기술 시장- 조사 범위

목차

제1장 서문

제2장 조사의 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

제5장 주요 인사이트

제6장 세계 시장 분석과 예측 : 기술별

제7장 세계 시장 분석과 예측 : 제제 유형별

제8장 세계 시장 분석과 예측 : 질환 유형별

제9장 세계 시장 분석과 예측 : 최종사용자별

제10장 세계 시장 분석과 예측 : 지역별

제11장 북미 시장 분석과 예측

제12장 유럽 시장 분석과 예측

제13장 아시아태평양 시장 분석과 예측

제14장 라틴아메리카 시장 분석과 전망

제15장 중동 및 아프리카 시장 분석과 예측

제16장 경쟁 구도